Robert A. Lipper
Impact in
- Pharmaceutical Science top 1%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
-
- Computational Drug Discovery Methods
Papers in
-
- Drug Solubulity and Delivery Systems 3
- Advanced Drug Delivery Systems 2
-
- Pharmaceutical studies and practices 3
- Co-authors
- William I. Higuchi (1 shared paper)Vinod P. Shah (2 shared papers)Kimberley A. Lentz (1 shared paper)Ankie M. Harmsze (1 shared paper)E Gupta (1 shared paper)Dirk M. Barends (1 shared paper)Jennifer Dressman (1 shared paper)Gordon L. Amidon (1 shared paper)
- Journals
- Journal of Pharmaceutical Sciences (4 papers)European Journal of Pharmaceutical Sciences (1 paper)The AAPS Journal (1 paper)Molecular Pharmacology (1 paper)PubMed (1 paper)
- Partner nations
- United StatesGermanySweden
In The Last Decade
Robert A. Lipper
9 papers receiving 402 citations
Peers
Comparison fields: 5 of 56
- Pharmaceutical Science 279
- Computational Theory and Mathematics 59
- Pediatrics, Perinatology and Child Health 40
- Analytical Chemistry 32
- Pharmacology 20
Countries citing papers authored by Robert A. Lipper
This map shows the geographic impact of Robert A. Lipper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Lipper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Lipper more than expected).
Fields of papers citing papers by Robert A. Lipper
This network shows the impact of papers produced by Robert A. Lipper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Lipper. The network helps show where Robert A. Lipper may publish in the future.
Co-authors
The 20 scholars most cited alongside Robert A. Lipper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 200 | |
| 2 | 2004 | 97 | |
| 3 | 2006 | 57 | |
| 4 | 1977 | 50 | |
| 5 | 2008 | 49 | |
| 6 | Inhibition of drug metabolism by a prodrug: 9-beta-D-arabinofuranosyladenine 5'-valerate as an inhibitor of adenosine deaminase. | 1978 | 8 |
| 7 | 1986 | 4 | |
| 8 | 2007 | 4 | |
| 9 | 1978 | 2 |
About Robert A. Lipper
Robert A. Lipper is a scholar working on Pharmaceutical Science, Pediatrics, Perinatology and Child Health, Toxicology, Health Information Management and Analytical Chemistry, having authored 9 papers that have together received 471 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (3 papers), Pharmaceutical studies and practices (3 papers), Advanced Drug Delivery Systems (2 papers), Biochemical and Molecular Research (2 papers), Analytical Methods in Pharmaceuticals (1 paper), Bioactive Compounds and Antitumor Agents (1 paper), Pharmaceutical Economics and Policy (1 paper) and Healthcare Regulation (1 paper). The work is most often cited by research in Pharmaceutical Science (279 citations), Computational Theory and Mathematics (59 citations), Pediatrics, Perinatology and Child Health (40 citations), Analytical Chemistry (32 citations) and Pharmacology (20 citations). Robert A. Lipper has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include William I. Higuchi, Vinod P. Shah, Kimberley A. Lentz, Ankie M. Harmsze, E Gupta, Dirk M. Barends, Jennifer Dressman, Gordon L. Amidon, Jack Cook and Paul H. Fackler. Their work appears in journals such as Journal of Pharmaceutical Sciences, European Journal of Pharmaceutical Sciences, The AAPS Journal, Molecular Pharmacology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.